CARTHAGE, MO — Stratum Nutrition®, a leading supplier of science-backed nutraceutical ingredients, announced that OraCMU™, a clinically researched oral probiotic ingredient developed by Oraticx, Inc., has received approval from Health Canada, enabling its sale and distribution in the Canadian natural health products market.

Health Canada's Product License (NPN 80149686) authorizes OraCMU™ powder for use as a natural health product that helps support and maintain oral health, promotes a healthy oral microbiota, and helps reduce halitosis (oral malodor) by supporting a healthy oral microbiota.

"Health Canada's approval marks a significant milestone for OraCMU™ and creates exciting new opportunities for our partners to bring innovative oral health solutions to Canadian consumers," said Arun Nair, Ph.D., Chief Commercial Officer at Stratum Nutrition. "As consumer interest in microbiome-focused wellness continues to accelerate, OraCMU™ provides brands with a clinically studied ingredient that promotes oral health by helping maintain a balanced oral microbiome."

OraCMU™ features the proprietary probiotic strain Weissella cibaria CMU, developed specifically to support oral health. Unlike traditional probiotics focused on digestive wellness, OraCMU™ is designed to help maintain a healthy oral microbiome while addressing the underlying causes of bad breath.

The Canadian approval further strengthens OraCMU’s global regulatory position and reinforces Stratum Nutrition's commitment to providing clinically validated ingredients that meet the evolving needs of consumers and brand partners worldwide.

*These statements have not been evaluated by the U.S. Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.